Cargando…

Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease, Volume II

Detalles Bibliográficos
Autores principales:	Bucolo, Claudio, Sanderson, Julie, Rossi, Settimio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197437/ https://www.ncbi.nlm.nih.gov/pubmed/35712725 http://dx.doi.org/10.3389/fphar.2022.915960

Ejemplares similares

Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease
por: Petrillo, Francesco, et al.
Publicado: (2021)

Editorial: Neurodegeneration, cell signaling and neuroreparative strategies, Volume II
por: Vaz, Ana Rita, et al.
Publicado: (2023)

Editorial: Chronic inflammation and pharmacological interventions in cardiovascular diseases, volume II
por: Yan, Aiwei, et al.
Publicado: (2023)

Editorial: Neurodegeneration and Neuroprotection in Retinal Disease, Volume II
por: Casini, Giovanni, et al.
Publicado: (2022)

Editorial: Autophagy in inflammation related diseases, volume II
por: Shao, Bo-Zong, et al.
Publicado: (2023)

Editorial: Neurobehavioral toxicity induced by environmental contaminants: mechanisms of neurodegeneration and neuroprotection, Volume II
por: Dorta, Daniel J., et al.
Publicado: (2023)

Vitamin D(3) preserves blood retinal barrier integrity in an in vitro model of diabetic retinopathy
por: Lazzara, Francesca, et al.
Publicado: (2022)

Caffeine Protects Against Retinal Inflammation
por: Conti, Federica, et al.
Publicado: (2022)

Stabilization of HIF-1α in Human Retinal Endothelial Cells Modulates Expression of miRNAs and Proangiogenic Growth Factors
por: Lazzara, Francesca, et al.
Publicado: (2020)

Editorial: Pharmacological approaches targeting neutrophilic inflammation: Volume II
por: Sokolov, Alexey V., et al.
Publicado: (2022)

Editorial: Resolution of inflammation: Mechanisms, mediators and biomarkers: Volume II
por: Patrignani, Paola, et al.
Publicado: (2022)

Editorial: Streaming inflammation: From damage to healing and resilience–Volume II
por: Devchand, Pallavi R., et al.
Publicado: (2023)

Editorial: Applications of herbal medicine to control chronic kidney disease: Volume II
por: Chen, Jianping, et al.
Publicado: (2022)

Biomarkers of Neurodegeneration and Precision Therapy in Retinal Disease
por: Micera, Alessandra, et al.
Publicado: (2021)

Editorial: Iron and neurodegeneration, volume II
por: Zanella, Isabella, et al.
Publicado: (2022)

Sulforaphane Modulates the Inflammation and Delays Neurodegeneration on a Retinitis Pigmentosa Mice Model
por: Canto, Antolín, et al.
Publicado: (2022)

Attenuation of High Glucose-Induced Damage in RPE Cells through p38 MAPK Signaling Pathway Inhibition
por: Maugeri, Grazia, et al.
Publicado: (2021)

Editorial: Neuroprotection and disease modification in Parkinson’s disease: Volume II
por: Otero-Losada, Matilde, et al.
Publicado: (2023)

Editorial: Infection, inflammation, and neurodegeneration: A critical path to Alzheimer's disease, Volume II
por: Mancuso, Roberta, et al.
Publicado: (2022)

Editorial: Therapeutic Index for Nutraceuticals in Inflammation-Related Diseases: Efficacy, Bioavailability, Metabolism and Interactions With Drugs, Volume II
por: Peluso, Ilaria, et al.
Publicado: (2022)

Editorial: Purinergic pharmacology, Volume II
por: Ciruela, Francisco, et al.
Publicado: (2023)

Editorial: Eicosanoids in cancer, Volume II
por: Patrignani, Paola, et al.
Publicado: (2023)

Editorial: Mitochondrial therapy in neurodegeneration
por: Kalani, Anuradha, et al.
Publicado: (2023)

Editorial: Ocular Pharmacology: Recent Breakthroughs and Unmet Needs
por: Bucolo, Claudio, et al.
Publicado: (2022)

Editorial: Channel Modulation in Neurodegeneration and Neuroprotection
por: Joubert, Jacques, et al.
Publicado: (2022)

Editorial: Novel therapeutic approaches for the treatment of ocular disease, Volume II
por: Thermos, Kyriaki, et al.
Publicado: (2022)

Editorial: Developing Medicines (Drugs) derived from the Asteraceae—an opportunity in ethnopharmacology, Volume II
por: da Silva, Luis Cláudio Nascimento, et al.
Publicado: (2023)

Editorial: Venoms, animal and microbial toxins, volume II
por: Cao, Zhijian, et al.
Publicado: (2022)

Editorial: Current Aspects in Chemopreventive Strategies, Volume II
por: Tuli, Hardeep Singh, et al.
Publicado: (2022)

Editorial: Antimalarial chemotherapy in the XXIst century, volume II
por: Gomes, Paula, et al.
Publicado: (2023)

Editorial: Cannabidiol treatment in neurotherapeutic interventions, volume II
por: Gonzalez-Cuevas, Gustavo, et al.
Publicado: (2023)

Editorial: Chronic inflammation and pharmacological interventions in cardiovascular diseases
por: Wang, Xiaoping, et al.
Publicado: (2022)

Editorial: Enteric inflammation and chronic diseases: Is there a link?
por: Marzocco, Stefania, et al.
Publicado: (2022)

Case Report: Central Retinal Artery Occlusion in a COVID-19 Patient
por: Montesel, Andrea, et al.
Publicado: (2020)

Editorial: Bone and Cartilage Diseases – The Role and Potential of Natural Products, Volume II
por: Pei, Ming, et al.
Publicado: (2023)

Editorial: Neurodegeneration, cell signaling and neuroreparative strategies
por: Vaz, Ana Rita, et al.
Publicado: (2022)

Editorial: Environmental effect on neuroinflammation and neurodegeneration, volume II
por: Sarkar, Souvarish, et al.
Publicado: (2023)

Editorial: Ferroptosis in stroke, neurotrauma and neurodegeneration, volume II
por: Xu, Weilin, et al.
Publicado: (2023)

Editorial: Imaging technology in oncology pharmacological research, volume II
por: Zeng, Qi, et al.
Publicado: (2022)

Editorial: Hydrogen sulfide: Physiology, Pharmacology and Toxicology, Volume II
por: Bian, Jin-Song
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qdjqfbrvmkoj0302nmdnlfnimg